FDA Approved New Drug Despite Ongoing Investigation of Lab Misconduct
Things aren’t improving for the FDA, as our series on how the agency handled fraudulent drug trial data continues.
Rob Garver
Freelance writing
Double Dose: In Second Case of Flawed Drug Research, FDA Response Was Slow and Secretive
Follow-up on our story from Monday about how the FDA handled fraudulent drug tests.
FDA let drugs approved on fraudulent research stay on the market
Check out this new investigative package on the FDA’s tepid response to drug trial fraud. My colleague Charles Seife and I spent months researching the story of how drugs approved by a research firm in Texas were left on the market, even after the FDA determined the company had committed pervasive “egregious” violations of Good Laboratory Practice.
Also: A frightening example of what happens when generic drugs aren’t the same as name brand drug here. And half a dozen drugs the FDA left on the market despite tainted data.
A Gig with ProPublica
I’m proud to say that after working with Bob Woodward for most of the past year, I now have the opportunity to spend some time working for ProPublica. I had often wondered what my next step would be after finishing work on Bob’s book, and whether I would be able to find an organization whose values and commitment to solid journalism matched his. In ProPublica, I believe I have, and I’m really pleased to be associated with it.
The Price of Politics
The Price of Politics debuted on the New York Times Bestseller list at #2 this week. I spent six months working with Bob Woodward, helping research, write and edit the book. In a note at the beginning of the book, Bob wrote: “Rob…is one of the best natural editors and reporters I have ever worked with.”
A writing hiatus
Since February, I have been working as senior research assistant to Bob Woodward, helping to research and write a book scheduled for publication in September 2012. My freelance work, as a result, is on hold until early 2013.
A New Idea in Bank Branding
With banks on the receiving end of a lot of public wrath these days, it might not seem to be the most opportune time to launch a new one. But a bank branding consultant in Oregon is pushing ahead anyway, with a unique – some might say strange – concept for a niche web-based financial institution.
Home Field Advantage
|
|||||
Should Mighty Walmart Be Regulated Like a Bank?
|
||||||
In Crises, Rhodes Was the Man in the Middle
|
|||||
